Skip to main content

How RNA Sequencing Can Help Improve Diagnosis of Rare Diseases?

 

RNA sequencing is a genomic approach for the identification and quantification analysis of RNA molecules with the ultimate aim of studying cellular responses from a biological sample. The advent of RNA sequencing had fueled several innovations in the medical sector, by facilitating other techniques (that utilize RNA sequencing) such as single nucleotide polymorphisms identification, RNA editing, transcriptional profiling and differential gene expression analysis.

RNA sequencing offers massive diagnostic utility in terms of rare diseases, which ranges from rare muscular disorders to mitochondrial diseases such as mitochondrial depletion syndrome, Leigh’s syndrome, and Kearns-Sayre syndrome, among others. RNA sequencing is an emerging technique to assess progression of different rare diseases. It aids medical professionals to understand various genes linked with specific rare diseases, thereby offering specific treatment for patients.

The rise in the discovery of genes associated with rare diseases coupled with the declining cost of genome sequencing is anticipated to enhance research in the rare disease segment. This is likely to support sequencing, particularly RNA sequencing, in the upcoming years.

Based on the market intelligence published by BIS Research, titled “Global RNA Sequencing Market - Analysis and Forecast, 2019-2028”, the market is expected grow at a significant CAGR of 14.21% during the forecast period, 2019-2028. This growth is driven by factors including increasing adoption of personalized medicine due to decreasing cost of sequencing and increasing utility in predictive biomarkers and therapeutic response research.

Further, amongst the various applications of the RNA sequencing, including drug discovery, translation medicine, diagnostics, and other, the drug discovery segment emerges as a prominent segment. The segment contributed approximately 44.50% share in 2018 and is expected to cover a significant share in the application segment in 2028. This segment is driven by the increase in use of RNA sequencing to modify drugs to suit the requirements of a specific patient owing to the incorporation of precision medicine.

In the RNA sequencing segment, there are several needs that are yet to be addressed by the stakeholders present in the market. These needs are related to shortage of skilled professionals in the field of bioinformatics and genomics. To fulfil this shortage of skilled professionals, regulations for quality analysis and interpretation of sequencing results are required to be established.

Labels:

Comments

Post a Comment

Popular posts from this blog

Personal Care Ingredients Market Size, Share & Trends Analysis Report 2019-2029

The introduction and proliferation of bio-based ingredients in several industries, such as food and beverage, pharmaceuticals, and cosmetics, has been transforming the manufacturing landscape since 2000. Growing consumer inclination toward the adoption of bio-based products due to rising health and environmental concerns is driving the demand for bio-based ingredients in the cosmetics and personal care products. Besides, awareness among consumers regarding the harmful effects of synthetic ingredients chemicals has grown rapidly over the past years. In addition, the availability of green raw materials has also urged large cosmetic firms to develop bio-based cosmetic products. However, limited availability of raw material, due to erratic weather conditions and stringent environmental regulations, can pose substantial hurdles in the production of bio-based ingredients. Thus, leading companies have been focusing on developing new and sustainable ways of producing the ingredi...
Post a Comment
Read more

Strategies Incorporated to Sustain the Competition

  The strategies followed by various prominent companies to sustain the competition and expand their market share has been varying from mergers and acquisitions (M&A) to collaborations and partnerships. In the past three years (January 2017-September 2020), the market witnessed approximately eight M&A activities, seven partnerships, and alliances (collaborations, joint ventures, and other agreements), one business expansion, and four other developments. Among the different key developments, M&A activities constitute the dominant contributor’s strategies, followed by partnership and alliances. The global bioengineered skin substitutes market is dominated by juggernauts including AbbVie, Inc., Integra LifeSciences Corporation, Smith & Nephew plc, and Stryker Corporation, and other medium and small-medium enterprises that are offering wide ranges of bioengineered skin substitute products in the market. Several companies are attempting to enter the market and sustain...
Post a Comment
Read more

ADAS and Autonomous Driving Component Market

As per the recent BIS Research report, the ADAS and autonomous driving component market is segmented into component type, level of autonomy, vehicle type, and region for the purpose of study. These segments are further sub-segmented into various categories. In case of market by component type, it is sub-segmented into camera, radar, ultrasonic sensors, LiDAR, and ECU. The use of LiDAR is increasing rapidly in the market owing to reducing cost of LiDAR sensors and their greater range.
Post a Comment
Read more